TITLE

Dapsone-Trimethoprim for Pneumonia in the Acquired Immunodeficiency Syndrome

AUTHOR(S)
Leoung, Clifford S.; Mills, John; Hopewell, Philip C.; Hughes, Walter; Wofsy, Constance
PUB. DATE
July 1986
SOURCE
Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that examined the efficacy of dapsone plus trimethoprim for the treatment of patients with AIDS and a first episode of Pneumocystis carinii pneumonia. Methodology; Characteristics of patients with AIDS and Pneumocystis carinii pneumonia treated with dapsone-trimethoprim; Results and discussion.
ACCESSION #
6998544

 

Related Articles

  • Improved Treatment For Pneumocystis. Helquist, Michael // Advocate;10/13/87, Issue 483, p23 

    Reports on the efficacy of aerosol pentamidine against pneumocystis carinii pneumonia in persons with AIDS. Absence of side effects; Reduction in average hospital stay.

  • DELAYING THE ONSET OF ILLNESS. Cohan, Gary R. // Advocate;2/8/94, Issue 648, p34 

    Reports that prophylaxis against Pneumocystis carinnii infection may delay the onset of the first AIDS-related illness.

  • FDA Grants Initial OK To AIDS Drug. Harding, Rick // Advocate;3/14/89, Issue 520, p14 

    Reports that the United States Food and Drug Administration (FDA) approved the use of an aerosol form of the drug, pentamidine to fight Pneumocystis carinii pneumonia associated with AIDS deaths. Properties of the product; Recommendations for further trials.

  • Trimethoprim-Sulfamethoxazole or Pentamidine for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome. Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C. // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37 

    Presents a study that examined the efficacy of trimethoprim-sulfamethoxazole or pentamidine isethionate for the treatment of Pneumocystis carinii pneumonia in patients with AIDS. Medical history of the patients; Methodology; Results and discussion.

  • Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. Helweg-Larsen, Jannik; Benfield, Thomas; Atzori, Chiara; Miller, Robert F. // Journal of Antimicrobial Chemotherapy (JAC);Dec2009, Vol. 64 Issue 6, p1282 

    Objectives: First-line therapy for Pneumocystis jirovecii pneumonia (PCP) is trimethoprim/sulfamethoxazole. Few data exist to guide the choice of second-line therapy for patients failing or developing toxicity to first-line therapy.

  • Inhaled or Intravenous Pentamidine Therapy for Pneumocystis carinii Pneumonia in AIDS. Soo Hoo, Guy W.; Mohsenifar, Zab; Meyer, Richard D. // Annals of Internal Medicine;8/1/90, Vol. 113 Issue 3, p195 

    Compares inhaled pentamidine with intravenous pentamidine for the treatment of Pneumocystis carinii pneumonia in AIDS. Standard therapy for Pneumocystis carinii pneumonia; Toxicity associated with pentamidine therapy; Characteristics of patients in greater respiratory distress.

  • Dapsone.  // Reactions Weekly;9/16/2006, Issue 1119, p11 

    The article focuses on a case report involving the effect of the drug dapsone in treating Pneumocystis carinii pneumonia in a child. Dapsone was administered to an 11-year-old boy with a history of chronic immune thrombocytopenic purpura. Within 24 hours, the patient had blue lips. Two days...

  • Trimethoprim--Sulfamethoxazole Compared with Pentamidine for Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome. Sattler, Fred R.; Cowan, Robert; Nielsen, Donald M.; Ruskin, Joel // Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p280 

    Ascertains the efficacy and toxicity of trimethoprim-sulfamethoxazole or pentamidine during the treatment period for Pneumocystis carinii pneumonia in patients with AIDS. Adverse drug effects; Dosage and treatment modifications; Determinants of toxicity; Effect of increased severity of illness.

  • Intravenous or Inhaled Pentamidine for Treating Pneumocystis carinii Pneumonia in AIDS. Conte, John E.; Chernoff, David; Feigal Jr., David W.; Joseph, Pat; McDonald, Charles; Golden, Jeffrey A. // Annals of Internal Medicine;8/1/90, Vol. 113 Issue 3, p203 

    Evaluates the efficacy and toxicity of aerosolized pentamidine and of reduced-dose intravenous pentamidine for treating Pneumocystis carinii Pneumonia in patients with AIDS. Characteristics of patients receiving the treatment; Information on pentamidine pharmacokinetics; Correlation between...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics